Literature DB >> 24473407

Cisplatin binds to human copper chaperone Cox17: the mechanistic implication of drug delivery to mitochondria.

Linhong Zhao1, Qinqin Cheng, Zhen Wang, Zhaoyong Xi, Dechen Xu, Yangzhong Liu.   

Abstract

Cox17 facilitates the platinum accumulation in mitochondria, which contributes to the overall cytotoxicity of cisplatin.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24473407     DOI： 10.1039/c3cc48847k

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN： 1359-7345            Impact factor:   6.222


  9 in total

Review 1.  Targeting drug transport mechanisms for improving platinum-based cancer chemotherapy.

Authors:  Helen H W Chen; Wen-Chung Chen; Zhang-Dong Liang; Wen-Bin Tsai; Yan Long; Isamu Aiba; Siqing Fu; Russell Broaddus; Jinsong Liu; Lynn G Feun; Niramol Savaraj; Macus Tien Kuo
Journal:  Expert Opin Ther Targets       Date:  2015-05-25       Impact factor: 6.902

2.  Interactions of cisplatin and the copper transporter CTR1 in human colon cancer cells.

Authors:  Mia C Akerfeldt; Carmen M-N Tran; Clara Shen; Trevor W Hambley; Elizabeth J New
Journal:  J Biol Inorg Chem       Date:  2017-05-17       Impact factor: 3.358

3.  Copper transporters and chaperones CTR1, CTR2, ATOX1, and CCS as determinants of cisplatin sensitivity.

Authors:  Kristin M Bompiani; Cheng-Yu Tsai; Felix P Achatz; Janika K Liebig; Stephen B Howell
Journal:  Metallomics       Date:  2016-05-09       Impact factor: 4.526

4.  Effect of temperature on the interaction of cisplatin with the model protein hen egg white lysozyme.

Authors:  Giarita Ferraro; Andrea Pica; Irene Russo Krauss; Francesca Pane; Angela Amoresano; Antonello Merlino
Journal:  J Biol Inorg Chem       Date:  2016-04-04       Impact factor: 3.358

5.  DNA damage repair-related gene signature predicts prognosis and indicates immune cell infiltration landscape in skin cutaneous melanoma.

Authors:  Liping Liang; Shijie Mai; Genghui Mai; Ye Chen; Le Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-26       Impact factor: 6.055

Review 6.  Modulating Chemosensitivity of Tumors to Platinum-Based Antitumor Drugs by Transcriptional Regulation of Copper Homeostasis.

Authors:  Yu-Hsuan Lai; Chin Kuo; Macus Tien Kuo; Helen H W Chen
Journal:  Int J Mol Sci       Date:  2018-05-16       Impact factor: 5.923

7.  Oxidation of Human Copper Chaperone Atox1 and Disulfide Bond Cleavage by Cisplatin and Glutathione.

Authors:  Maria I Nardella; Antonio Rosato; Benny D Belviso; Rocco Caliandro; Giovanni Natile; Fabio Arnesano
Journal:  Int J Mol Sci       Date:  2019-09-06       Impact factor: 5.923

Review 8.  Activity and Trafficking of Copper-Transporting ATPases in Tumor Development and Defense against Platinum-Based Drugs.

Authors:  Raffaella Petruzzelli; Roman S Polishchuk
Journal:  Cells       Date:  2019-09-13       Impact factor: 6.600

9.  Synthetic Lethality Screening Identifies FDA-Approved Drugs that Overcome ATP7B-Mediated Tolerance of Tumor Cells to Cisplatin.

Authors:  Marta Mariniello; Raffaella Petruzzelli; Luca G Wanderlingh; Raffaele La Montagna; Annamaria Carissimo; Francesca Pane; Angela Amoresano; Ekaterina Y Ilyechova; Michael M Galagudza; Federico Catalano; Roberta Crispino; Ludmila V Puchkova; Diego L Medina; Roman S Polishchuk
Journal:  Cancers (Basel)       Date:  2020-03-06       Impact factor: 6.639
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.